Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. - Wikidata - wikimedia - TriplyDB

Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.

Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.

http://www.wikidata.org/entity/Q37362211

about

Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers.Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers.Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example Non-iterative, regression-based estimation of haplotype associations with censored survival outcomes.TOPBP1 takes RADical command in recombinational DNA repair Genetic evaluation of BRCA1 associated a complex genes with triple-negative breast cancer susceptibility in Chinese women.Prognostic value of CtIP/RBBP8 expression in breast cancer.Hereditary ovarian and breast cancer: what have we learned?Breast cancer prevention with anti-estrogens: review of the current evidence and future directions.BARD1: an independent predictor of survival in non-small cell lung cancer.Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time?

P2860

Q33943829-CE841E89-7A30-4510-ABFF-F75E87546E8E Q34435034-71978BC9-8469-4ED6-A58C-00791CDF456B Q34949394-5974AE9C-1916-4997-8ECF-2914DFF126D1 Q35022825-20EAD440-4783-4600-8790-81EEE268E436 Q35060014-496651E8-018D-48AD-949D-872110F525AE Q35207476-E946D5E9-0281-4C8A-BCC1-88ABDC1B9339 Q35631708-1D98460F-8719-4EAA-8D0B-F58F09AFD905 Q36090710-30EA3DB1-BC0F-4885-BF0D-FF14EEC759DE Q36565985-21B934F7-095A-4FCA-816E-F9836C12E372 Q36962780-A5E4D206-403D-4190-9F0E-9F6EFA5AD1E7 Q37481139-7BCE6A5B-0E8C-4A4F-8DDA-C2148B415A2E Q38153188-2E5DB417-CCEA-4A2B-AB1B-E54560F20E88 Q38599973-189B6FDE-1CAB-45A4-ADEE-45882DCEE609 Q39495392-7175D074-1C01-4C20-A166-FB70D9CCC0F0 Q48506802-E699B3D3-950C-48D5-8305-7229E53F47E0

P2860

Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.

http://www.wikidata.org/entity/Q37362211

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Modification of ovarian cancer ...... of BRCA1/2 mutation carriers.

@en

Modification of ovarian cancer ...... of BRCA1/2 mutation carriers.

@nl

type

label

Modification of ovarian cancer ...... of BRCA1/2 mutation carriers.

@en

Modification of ovarian cancer ...... of BRCA1/2 mutation carriers.

@nl

prefLabel

Modification of ovarian cancer ...... of BRCA1/2 mutation carriers.

@en

Modification of ovarian cancer ...... of BRCA1/2 mutation carriers.

@nl

P1433

Q37362211-6C770559-984E-40B6-967E-0074889C6680

P1476

Q37362211-F882B53D-19E6-4935-AA66-28AF760374FF

P2093

Q37362211-25E54B84-1515-4B1D-8B7E-834C4AAF0E29

Q37362211-2883E526-9FEE-4674-BAA2-06CEC2B6628E

Q37362211-3F9805FD-FA5A-4C9B-89F6-8AC684053D19

Q37362211-4A5BC9F2-5DFA-4AE4-B0C9-840E44BEC14A

Q37362211-547A7D15-CC19-4EC1-BA05-8C63A42E0B7A

Q37362211-5B9172CB-C00C-45C0-B346-9A024B29BDCD

Q37362211-5F50040A-B817-45E5-94B1-0119EBF611BC

Q37362211-622E10FA-B221-42EB-9807-86E96C1104ED

Q37362211-68E7FCCF-8725-4B14-9F30-A3BEDF4DC655

Q37362211-734DC971-4804-4090-AA2D-E55092BC6284

P2860

Q37362211-0990652B-3BD1-4995-8E5A-CD50245EF3D5

Q37362211-13ED35FF-49E3-4609-AB25-AE28778103C8

Q37362211-17388698-7FD2-4FF0-8D19-2A8429CF065D

Q37362211-1E0FB4B3-B2CF-44F3-B262-C6CB79486798

Q37362211-38BD04B3-0E4D-4C68-9E01-3B1B6DB6EA6E

Q37362211-4372F1C2-2723-401A-BDA8-19FFB138B80F

Q37362211-496BEDF8-5306-44F3-A05B-F586718B6E95

Q37362211-51572642-2E78-444B-8ED1-10D3D75C4665

Q37362211-5A4B8EE6-F7BD-4300-A08D-198CE07C17C2

Q37362211-60379F1B-D4AB-41ED-B358-865055E661A8

P304

Q37362211-EFF2CBBF-04A8-48AC-90AE-C453F115865B

P31

Q37362211-E05C6A5D-5DFF-4FC1-8142-0DB6306A50BA

P356

Q37362211-9B909F2E-3599-4BA5-BD7D-97F7F5F54E19

P407

Q37362211-A0C8750C-4A81-40B8-ADF2-3CA9A352FFC7

P433

Q37362211-B18A641D-42CD-4D0E-957B-5B36436D891F

P478

Q37362211-5646BFB0-2EDB-41BC-995E-486DC2808938

P50

Q37362211-240E4585-9B94-4A35-A7D1-A43D2AA6C7B6

Q37362211-2B3AD6EE-D44B-4774-AFDA-702EC8DC6D64

Q37362211-4EF923D7-4486-4746-A351-FE99279D7C16

Q37362211-5FA641CD-1C17-4CA3-9824-1E0D9BAA5714

Q37362211-97B01E30-2EEC-4857-B75C-58BE6F4E6F31

Q37362211-A2B14564-B0B5-4E9A-A566-F54C531ED9F9

Q37362211-A9B94EF2-5EC5-43E2-A0FE-48E25E73365D

Q37362211-C33154F4-EF42-4A58-B6BE-EAD6CFCB08BF

Q37362211-C4EBF6FF-1FE0-4968-9A33-2B1DA93B69E2

Q37362211-F87A382A-68CF-43BE-955F-6158CCE46E7A

P577

Q37362211-0266ADD2-FEF4-4552-9576-26A3414ACC96

P5875

Q37362211-1E560231-0161-40BE-A761-F11BFFF107E4

P698

Q37362211-8106DEA0-D311-46E0-A2DE-B803AB21147C

P921

Q37362211-55049B9D-2CBC-446C-8BC1-7F6EE923A077

Q37362211-85813B60-F813-469A-99F8-C154FA030201

P932

Q37362211-31BD8EE5-2E97-45A9-A32F-E4A25BD93231

P356

0008-5472.CAN-09-0625

P1433

Cancer Research

P1476

Modification of ovarian cancer ...... of BRCA1/2 mutation carriers.

@en

P2093

Christian F Singer

http://www.w3.org/2001/XMLSchema#string

Fei Wan

http://www.w3.org/2001/XMLSchema#string

Gail E Tomlinson

http://www.w3.org/2001/XMLSchema#string

Georg Pfeiler

http://www.w3.org/2001/XMLSchema#string

Henry T Lynch

http://www.w3.org/2001/XMLSchema#string

Joanne L Blum

http://www.w3.org/2001/XMLSchema#string

Judy E Garber

http://www.w3.org/2001/XMLSchema#string

Mary B Daly

http://www.w3.org/2001/XMLSchema#string

Nadine Tung

http://www.w3.org/2001/XMLSchema#string

Nandita Mitra

http://www.w3.org/2001/XMLSchema#string

P2860

BRCA2 and homologous recombination

Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures

Distinct functions of BRCA1 and BRCA2 in double-strand break repair

The Fanconi anaemia/BRCA pathway

Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways

Interaction of FANCD2 and NBS1 in the DNA damage response

Cancer susceptibility and the functions of BRCA1 and BRCA2

Association of BRCA1 with Rad51 in mitotic and meiotic cells

P304

5801-5810

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-09-0625

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Georgia Chenevix-Trench

Katherine L Nathanson

Amanda B. Spurdle

Steven A. Narod

Susan M Domchek

Fergus J. Couch

Susan L Neuhausen

Jeffrey N Weitzel

Olufunmilayo Olopade

Claudine Isaacs

P577

2009-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26653759

http://www.w3.org/2001/XMLSchema#string

P698

19584272

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

2751603

http://www.w3.org/2001/XMLSchema#string